NVAX

NOVAVAX, INC

NVAX · CIK 1000694 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$1.1B
20182025
Net Income$0.4B
20182025
Operating CF−$0.2B
20182025
Free Cash Flow
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$1.1B$0.7B$1.0B$2.0B$1.1B$0.5B$0.0B$0.0B
Cost of Revenue$0.1B$0.2B$0.3B$0.9B————
Gross Profit————————
R&D Expense$0.3B$0.4B$0.7B$1.2B$2.5B$0.7B$0.1B$0.2B
SG&A Expense$0.2B$0.3B——————
Operating Income$0.5B$-0.2B$-0.6B$-0.6B$-1.7B$-0.4B$-0.1B$-0.2B
Net Income$0.4B$-0.2B$-0.5B$-0.7B$-1.7B$-0.4B$-0.0B$-0.0B
EPS (Basic)$2.72$-1.23$-5.41$-8.42$-23.44———
EPS (Diluted)$2.58$-1.23$-5.41$-8.42$-23.44———

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$1.2B$1.6B$1.8B$2.3B$2.6B$1.6B$0.2B$0.2B
Current Assets$1.0B$1.1B$1.1B$1.7B$2.2B$1.2B$0.1B$0.1B
Cash & Equivalents$0.2B$0.5B$0.6B$1.3B$1.5B$0.6B$0.1B$0.1B
Total Liabilities$1.3B$2.2B$2.5B$2.9B$2.9B$1.0B$0.4B$0.4B
Current Liabilities$0.5B$1.2B$1.6B$2.5B$2.4B$0.6B$0.0B$0.0B
Stockholders' Equity$-0.1B$-0.6B$-0.7B$-0.6B$-0.4B$0.6B$-0.2B$-0.2B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$-0.2B$-0.1B$-0.7B$-0.4B$0.3B$-0.0B$-0.1B$-0.2B
Investing Cash Flow$-0.1B$-0.2B$-0.1B$-0.1B$0.1B$-0.4B$0.0B$0.0B
Capital Expenditures————————
Financing Cash Flow$0.0B$0.3B$0.0B$0.3B$0.5B$1.0B$0.1B$0.1B
← Companies